SciTransfer
Organization

SUN YAT-SEN UNIVERSITY

Major Chinese university contributing neurotoxicology, rapid diagnostics, and environmental health expertise to European research consortia.

University research grouphealthCNNo active H2020 projectsThin data (2/5)
H2020 projects
4
As coordinator
0
Total EC funding
€206K
Unique partners
65
What they do

Their core work

Sun Yat-sen University is a major Chinese research university based in Guangzhou with selective but targeted involvement in European research. Their H2020 contributions center on health-related research — specifically the neurotoxic effects of transport-derived air pollution on the brain, and rapid diagnostic tools for infectious diseases like COVID-19. They also bring expertise in agricultural waste valorization and smart transport technologies, reflecting a broad life sciences and environmental research base.

Core expertise

What they specialise in

Neurotoxicology and brain health impacts of air pollutionprimary
1 project

TUBE project (2019-2023) investigated transport-derived ultrafine particles and their effects on brain health, Alzheimer's disease, and neuroinflammation.

Rapid diagnostic tests and point-of-care instrumentsprimary
1 project

CORONADX project (2020-2023) developed three rapid COVID-19 diagnostic tests with associated epidemiological and socio-economic analysis.

Smart transport and ICT evaluationsecondary
1 project

TESTBED project (2017-2019) tested and evaluated advanced ICT for enabling smart transport systems.

Evolution & trajectory

How they've shifted over time

Early focus
Applied technology and agriculture
Recent focus
Environmental health and diagnostics

Sun Yat-sen University's early H2020 involvement (2016-2017) covered broad applied topics — agricultural waste management and smart transport ICT — without a strong thematic signature. From 2019 onward, they shifted decisively toward health and biomedical research, focusing on the neurotoxic effects of nanoparticles from traffic and rapid point-of-care diagnostics. This recent concentration on environmental health impacts and diagnostic technology represents a clear narrowing toward medically relevant, translational research.

Moving toward health-oriented research at the intersection of environmental exposure science and rapid diagnostics — expect future interest in air pollution health impacts and point-of-care medical devices.

Collaboration profile

How they like to work

Role: specialist_contributorReach: Global19 countries collaborated

Sun Yat-sen University exclusively participates as a partner or third party — they have never coordinated an H2020 project, which is typical for non-EU institutions joining European consortia as international collaborators. With 65 unique partners across 19 countries from just 4 projects, they join large, well-connected consortia rather than small focused teams. This suggests they are brought in for specific expertise contributions rather than driving project direction.

Despite only 4 projects, they have built connections with 65 partners across 19 countries, indicating participation in large multi-national consortia. Their network spans broadly across Europe and beyond, reflecting their role as a valued international collaborator brought into established European research groups.

Why partner with them

What sets them apart

As a top-tier Chinese university, Sun Yat-sen brings access to large patient populations, extensive in vitro and in vivo testing capabilities, and a research infrastructure that complements European partners. Their combination of inhalation toxicology expertise with brain health research is relatively rare and positions them well for projects linking environmental exposure to neurological disease. For consortia needing a strong Asian partner with health sciences depth, they are a credible choice with proven H2020 experience.

Notable projects

Highlights from their portfolio

  • TUBE
    Directly links traffic-generated nanoparticles to brain diseases including Alzheimer's — a high-impact, cross-disciplinary topic bridging transport and health.
  • CORONADX
    Their only funded project (EUR 205,895), developing rapid COVID-19 diagnostics — demonstrates capability in point-of-care medical device research with clear real-world urgency.
Cross-sector capabilities
transport and air qualityfood and agricultural wasteenvironmental toxicologysmart ICT systems
Analysis note: Limited H2020 footprint with only 4 projects and minimal funding data (only 1 project shows EC contribution). As a non-EU institution, their participation is inherently constrained. The profile is based on sparse data; their actual research capabilities are likely much broader than what H2020 records show. Early-period keyword data is empty, limiting the evolution analysis.